Supplementary Figures S1 to S36

Slides:

Advertisements

Similar presentations

What does multiple mean?. X2 TABLE: 2, 4, 6, 8, 10, 12, 14, 16, 18, , , … What pattern do you notice?

Advertisements

Table 1. 14,4 kDa 18,8 kDa 25 kDa 35 kDa 45 kDa 116 kDa Figure 1 Healthy control sera Secondary Ab RA sera Antigenic targets wrist RA SM Antigenic targets.

Database Searches. Peptide mass fingerprinting digestMS Search HIT SCORE Protein X 1000 Protein Y 50 Protein Z 5 Protein X theoretical digestProtein Y.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Figure Figure 18-1 part 1 Figure 18-1 part 2.

1 times table 2 times table 3 times table 4 times table 5 times table

Investigating the effects of human aldehyde dehydrogenase on vaccinia virus replication in breast cancer stem cells Mazin Elsarrag BNFO /4/2014.

Figure 1S. BSR homology. Exhaustive pairwise alignment using neighbour-joining phylogeny analysis by Clone Manager7 software shows the high homology of.

Precursor m/z double charge iTRAQ ratio 114: iTRAQ ratio 116: iTRAQ ratio 121: Precursor m/z triple charge iTRAQ.

Supplementary Figure 1A. Striatal correlation pattern of D2BP with BMI corrected for age as represented by t-maps. A Negative Correlation Positive Correlation.

Supplementary Figure 1: There was no significant difference among groups of placebo, calcium carbonate, milk mineral and milk drink with regard to age.

Figure S1 Figure S1. Effect of MeJA on spore germination of M. oryzae. The data presented were the means (± standard error) of spore germination from three.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

The observed and theoretical peptide sequence information Cal.MassObserved. Mass ±da±ppmStart Sequence EndSequenceIon Score C.I%modification FLPVNEK.

Spot number ; H1 Supporting Information Figure 3. MS spectra of the identified proteins.

Tables Learning Support

Breaking down the structure of the enzyme ALDH2: 1 tequila, 2 tequila…..ASIAN FLUSH!

On page 2: Saturation curves for determination of PsAMADH1 and 2 activities with variable concentrations of NAD + in the presence of 1 mmol l -1 aldehyde.

CompoundFormulaCalculated [M+H] + Observed [M+H] + DifferenceError, ppm 3C 35 H 27 N 7 O C 56 H 45 N 7 O

Deducing protein composition from complex protein preparations by MALDI without peptide separation.. TP #419 Kenneth C. Parker SimulTof Corporation, Sudbury,

Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.

Aldehyde Dehydrogenase Zach Lawton 1. Background Superfamily of Nictonamide adenine dinucleotide phosphate (NADP) enzymes Location: all three domains.

Invest. Ophthalmol. Vis. Sci ;50(12): doi: /iovs Figure Legend:

Supplementary Figure S4

Figure S1. A B C Survival probability (%) P = 0.21 P = 0.37 P = 0.12

Fundamentals of Biochemistry

Oxidative metabolism of (A) methanol, (B) ethanol, and (C) isopropanol

Supplemental Table 1. Sensitivity analysis comparing mixed effects Poisson regression with robust error variance using imputed versus non-missing SBP.

The Molecular Revolution in Cutaneous Biology: Keratin Genes and their Associated Disease: Diversity, Opportunities, and Challenges Pierre A. Coulombe

Figures & Tables from the textbook.

Zhao Jing, M. D. , Zhang Qiong, M. D. , Wang Yonggang, M. D

Statistical analysis of the influence of network regulators on topology clusters in the oleate network. Statistical analysis of the influence of network.

A. C. B. D. Bifidobacterium mono-culture Bifidobacterium mono-culture

The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease

Representative Examples of NGF and SK2 Protein Expression Within LSG A and B show representative Western blot images of NGF and SK2; C and D show corresponding.

Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms Sigitas.

Identification of genes associated with a gain of prion susceptibility Increased susceptibilities of revertant cell clones R2, R5 and R7 after retinoic.

Mass Spectrometry PROBLEM SET II

Nat. Rev. Nephrol. doi: /nrneph

Mass Spectrometer.

Figure 5 Mendelian randomization of biomarkers on the same pathway

Foxc1 Ablated Mice Are Anhidrotic and Recapitulate Features of Human Miliaria Sweat Retention Disorder Chang-Yi Cui, Ryuga Ishii, Dean P. Campbell, Marc.

Volume 17, Issue 2, Pages (August 2002)

Validation of proteins identified by mass spectrometry.

Identification of chaperonin GroEL (Rv0440) with representative MS/MS spectrum. Identification of chaperonin GroEL (Rv0440) with representative MS/MS spectrum.A,

Figure Overview.

Volume 17, Issue 2, Pages (August 2002)

Figure Overview.

Effects of the Aminophenol Analogue p-Dodecylaminophenol on Mouse Skin

Rounding and estimating: Spot the significant figure

3 times tables.

6 times tables.

Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified by Maja Ludvigsen, Martin.

What I expect to see in Skyline

A B C D E F Supplementary Fig. 3. Gating strategy for ES2 ALDHhi tumor initiating cells (TIC). Cells were treated with the specific aldehyde dehydrogenase.

Supplementary Figures

Figure 1. Chloride channel-3 (CIC-3) expression in breast tumor tissues. (A) Chloride channels (ClC-1–7, CFTR) are expressed in human breast cancer tissues.

Supplement Figure 1 Untreated Thermal IMDP CPLL Untreated Thermal IMDP

Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.

Chapter 1 Functions.

ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition Weixuan.

--- 6-months’ therapy months’ therapy Supplementary Figure 1.

Upregulated SCPs in MFS mice Upregulated SCPs in MFS patients

Here are a mixture of integers and decimal values.

BCAA Degradation during TAG Accumulation

Presentation transcript:

Supplementary Figures S1 to S36 PMF mass spectra and protein identification results: Table1 (upregulated in IPF and fNSIP versus Controls): Suppl. Figures S1-S14 1

Suppl. Figure S1, SPOT 2780 2

Spot 2780 3

Spot 2780 4

Suppl. Figure S2, SPOT 2981 5

Spot 2981 6

Spot 2981 7

Suppl. Figure S3, SPOT 3012 8

Spot 3012 9

Spot 3012 10

Suppl. Figure S4, SPOT 3032 11

Spot 3032 12

Spot 3032 13

Suppl. Figure S5, SPOT 3064 14

Spot 3064 15

Spot 3064 16

Suppl. Figure S6, SPOT 3104 17

Spot 3104 18

Spot 3104 19

Suppl. Figure S7, SPOT 3158 20

Spot 3158 21

Spot 3158 22

Suppl. Figure S8, SPOT 2719 23

No significant identification Spot 2719 No significant identification 24

No significant identification Spot 2719 No significant identification 25

Suppl. Figure S9, SPOT 3178 26

No significant identification Spot 3178 27

No significant identification Spot 3178 No significant identification 28

Suppl. Figure S10, SPOT 2881 29

Spot 2881 30

Spot 2881 31

Suppl. Figure S11, SPOT 3089 32

Spot 3089 33

Spot 3089 34

Suppl. Figure S12, SPOT 3550 35

Spot 3550 36

Spot 3550 37

Suppl. Figure S13, SPOT 2922 38

Spot 2922 39

Spot 2922 40

Suppl. Figure S14, SPOT 3219 41

Spot 3219 42

Spot 3219 43

PMF mass spectra and protein identification results: Table 2 (Downregulated in IPF and fNSIP versus Controls) Supplementary Figures S15-S26 44

Suppl. Figure S15, SPOT 2799 45

Spot 2799 46

Spot 2799 47

Suppl. Figure S16, SPOT 2854 48

Spot 2854 49

Spot 2854 50

Suppl. Figure S17, SPOT 2949 51

Spot 2949 52

Spot 2949 53

Suppl. Figure S18, SPOT 3077 54

Spot 3077 55

Spot 3077 56

Suppl. Figure S19, SPOT 3170 57

Spot 3170 58

Spot 3170 59

Suppl. Figure S20, SPOT 2959 60

Spot 2959 61

Spot 2959 62

Suppl. Figure S21, SPOT 2907 63

Spot 2907: ACTB or ACTG 64

Suppl. Figure S22, SPOT 3232 65

Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2 Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2. Selenium binding protein SBP1 66

Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2 Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2. Selenium binding protein SBP1 67

Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2 Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2. Selenium binding protein SBP1 68

Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2 Spot 3232: Mixture: 1. Aldehyde dehydrogenase ALDH2, 2. Selenium binding protein SBP1 69

Suppl. Figure S23, SPOT 2807 70

Spot 2807_2_another spectrum 71

No significant identification Spot 2807 No significant identification 72

Suppl. Figure S24, SPOT 3107 73

No significant identification Spot 3107 No significant identification 74

Suppl. Figure S25, SPOT 2903 75

Spot 2903 76

Spot 2903 77

Suppl. Figure S26, SPOT 2900 78

Spot 2900 79

Spot 2900 80

Supplementary Figures S27-S36 PMF mass spectra and protein identification results: Table 3: fNSIP versus IPF Supplementary Figures S27-S36 81

Suppl. Figure S27, SPOT 2714 82

Spot 2714 83

Spot 2714 84

Suppl. Figure S28, SPOT 2748 85

Spot 2748 86

Spot 2748 87

Suppl. Figure S29, SPOT 2904 88

Spot 2904 89

Spot 2904 90

Suppl. Figure S30, SPOT 2960 91

Spot 2960 92

Spot 2960 93

Suppl. Figure S31, SPOT 3072 94

Spot 3072: Mixture: 1. Cytokeratin-19 (KRT19), 2. Vimentin (VIME) 95

Spot 3072: Mixture: 1. Cytokeratin-19 (KRT19), 2. Vimentin (VIME) 96

Spot 3072: Mixture: 1. Cytokeratin-19 (KRT19), 2. Vimentin (VIME) 97

Spot 3072: Mixture: 1. Cytokeratin-19 (KRT19), 2. Vimentin (VIME) 98

Suppl. Figure S32, SPOT 3075 99

Spot 3075 100

Spot 3075 101

Suppl. Figure S33, SPOT 3175 102

Spot 3175 103

Spot 3175 104

Suppl. Figure S34, SPOT 3189 105

Spot 3189 106

Spot 3189 107

Suppl. Figure S35, SPOT 3191 108

Spot 3191 109

Spot 3191 110

Suppl. Figure S36, SPOT 3198 111

Spot 3198 112

Spot 3198 113